Written by: Phillip J. Minnick, Ph.D. Medical devices that contact the human body undergo biocompatibility safety assessments prior to market release,... Read More
Written by: Rhett D. Ramsey & Daniel Kiang JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. Before Prost, Dyk, and Hughes. Appeal... Read More
Written by: Zachary B. Messick & Jacob R. Rosenbaum SALIX PHARMACEUTICALS, LTD. v. NORWICH PHARMACEUTICALS., INC. Before Lourie, Chen, and... Read More
Written by: Brianne M. Kingery & Jason J. Jardine The Biden Administration’s Inflation Reduction Act (IRA)’s Medicare drug price negotiation program,... Read More
Written by: Christian Boettcher Orthobond received on April 5th de novo approval for the company’s spinal fusion device with quaternary ammonium compound coating. Orthobond’s antibacterial... Read More
Tomorrow marks the highly anticipated release of our fourth annual Trademark Intelligence Report, offering a comprehensive analysis of the trademark... Read More